Top Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 Earnings

Benzinga

2024-11-18

Twist Bioscience Corporation (NASDAQ:TWST) will release earnings results for its fourth quarter, before the opening bell on Monday, Nov. 18.

Analysts expect the South San Francisco, California-based bank to report a quarterly loss at 69 cents per share, versus a year-ago loss of 75 cents per share. Twist Bioscience projects to report revenue of $82.66 million for the recent quarter, compared to $66.95 million a year earlier, according to data from Benzinga Pro.

On Oct. 22, Twist Bioscience entered into royalty purchase agreement with xOMA Royalty for $15 million in cash.

Twist Bioscience shares fell 5.3% to close at $36.89 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

JP Morgan analyst Tycho Peterson maintained an Underweight rating and raised the price target from $28 to $35 on Aug. 5. This analyst has an accuracy rate of 77%.
Baird analyst Catherine Ramsey maintained an Outperform rating and raised the price target from $40 to $46 on Aug. 5. This analyst has an accuracy rate of 78%.
Goldman Sachs analyst Matthew Sykes maintained a Buy rating and increased the price target from $45 to $55 on July 9. This analyst has an accuracy rate of 64%.
TD Cowen analyst Steven Mah maintained a Buy rating and raised the price target from $55 to $65 on June 13. This analyst has an accuracy rate of 64%.

Considering buying TWST stock? Here’s what analysts think:

Read This Next:

How To Earn $500 A Month From Apple Stock

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2484676630"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2484676630\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2484676630?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-18 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484676630","market":"hk","top_or_hot":-1,"title":"Top Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 Earnings","media":"Benzinga","content":"<html><body><p><strong>Twist Bioscience Corporation</strong> (NASDAQ:TWST) will release earnings results for its fourth quarter, before the opening bell on Monday, Nov. 18.</p>\n<p>Analysts expect the South San Francisco, California-based bank to report a quarterly loss at 69 cents per share, versus a year-ago loss of 75 cents per share. Twist Bioscience projects to report revenue of $82.66 million for the recent quarter, compared to $66.95 million a year earlier, according to data from Benzinga Pro.</p>\n<p>On Oct. 22, Twist Bioscience entered into royalty purchase agreement with xOMA Royalty for $15 million in cash.</p>\n<p>Twist Bioscience shares fell 5.3% to close at $36.89 on Friday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>JP Morgan analyst Tycho Peterson maintained an Underweight rating and raised the price target from $28 to $35 on Aug. 5. This analyst has an accuracy rate of 77%.</li>\n<li>Baird analyst Catherine Ramsey maintained an Outperform rating and raised the price target from $40 to $46 on Aug. 5. This analyst has an accuracy rate of 78%.</li>\n<li>Goldman Sachs analyst Matthew Sykes maintained a Buy rating and increased the price target from $45 to $55 on July 9. This analyst has an accuracy rate of 64%.</li>\n<li>TD Cowen analyst Steven Mah maintained a Buy rating and raised the price target from $55 to $65 on June 13. This analyst has an accuracy rate of 64%.</li>\n</ul>\n<p>Considering buying TWST stock? Here’s what analysts think:</p>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>How To Earn $500 A Month From Apple Stock</strong></li>\n</ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 Earnings\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2024-11-18 22:43</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong>Twist Bioscience Corporation</strong> (NASDAQ:TWST) will release earnings results for its fourth quarter, before the opening bell on Monday, Nov. 18.</p>\n<p>Analysts expect the South San Francisco, California-based bank to report a quarterly loss at 69 cents per share, versus a year-ago loss of 75 cents per share. Twist Bioscience projects to report revenue of $82.66 million for the recent quarter, compared to $66.95 million a year earlier, according to data from Benzinga Pro.</p>\n<p>On Oct. 22, Twist Bioscience entered into royalty purchase agreement with xOMA Royalty for $15 million in cash.</p>\n<p>Twist Bioscience shares fell 5.3% to close at $36.89 on Friday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>JP Morgan analyst Tycho Peterson maintained an Underweight rating and raised the price target from $28 to $35 on Aug. 5. This analyst has an accuracy rate of 77%.</li>\n<li>Baird analyst Catherine Ramsey maintained an Outperform rating and raised the price target from $40 to $46 on Aug. 5. This analyst has an accuracy rate of 78%.</li>\n<li>Goldman Sachs analyst Matthew Sykes maintained a Buy rating and increased the price target from $45 to $55 on July 9. This analyst has an accuracy rate of 64%.</li>\n<li>TD Cowen analyst Steven Mah maintained a Buy rating and raised the price target from $55 to $65 on June 13. This analyst has an accuracy rate of 64%.</li>\n</ul>\n<p>Considering buying TWST stock? Here’s what analysts think:</p>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>How To Earn $500 A Month From Apple Stock</strong></li>\n</ul></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"https://www.benzinga.com/24/11/42038687/top-wall-street-forecasters-revamp-twist-bioscience-price-expectations-ahead-of-q4-earnings","article_id":"2484676630","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484676630","pubTimestamp":1731940996,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"华尔街顶级预测者在第四季度财报公布前修改了Twist Bioscience的价格预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":0.9},"content_text":"Twist Bioscience Corporation (NASDAQ:TWST) will release earnings results for its fourth quarter, before the opening bell on Monday, Nov. 18.\nAnalysts expect the South San Francisco, California-based bank to report a quarterly loss at 69 cents per share, versus a year-ago loss of 75 cents per share. Twist Bioscience projects to report revenue of $82.66 million for the recent quarter, compared to $66.95 million a year earlier, according to data from Benzinga Pro.\nOn Oct. 22, Twist Bioscience entered into royalty purchase agreement with xOMA Royalty for $15 million in cash.\nTwist Bioscience shares fell 5.3% to close at $36.89 on Friday.\nBenzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.\nLet's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.\n\nJP Morgan analyst Tycho Peterson maintained an Underweight rating and raised the price target from $28 to $35 on Aug. 5. This analyst has an accuracy rate of 77%.\nBaird analyst Catherine Ramsey maintained an Outperform rating and raised the price target from $40 to $46 on Aug. 5. This analyst has an accuracy rate of 78%.\nGoldman Sachs analyst Matthew Sykes maintained a Buy rating and increased the price target from $45 to $55 on July 9. This analyst has an accuracy rate of 64%.\nTD Cowen analyst Steven Mah maintained a Buy rating and raised the price target from $55 to $65 on June 13. This analyst has an accuracy rate of 64%.\n\nConsidering buying TWST stock? Here’s what analysts think:\nRead This Next: \n\nHow To Earn $500 A Month From Apple Stock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}